However, GSTM3 acts as a tumour suppressor to inhibit tumourigenesis in gastric cancer, alleviate the aggressiveness in renal cell carcinoma, and alter the malignant metabolic pattern in pancreatic cancer [25, 26, 47]. This evidence concerns the gene GSTM3 and pancreatic neoplasm.